Results 121 to 130 of about 73,286 (248)
Candidiasis vulvovaginal y factores de riesgo en mujeres de 20 a 49 años atendidas en el Puesto de Salud de Nuevo Horizonte, 2023 [PDF]
La presente investigación tuvo como objetivo determinar la Prevalencia y factores de riesgo de candidiasis vulvovaginal en mujeres de 20 a 49 años atendidas en el Puesto de Salud de Nuevo Horizonte, en el año 2023.
Quinde Pintado,Jhon Anthony +1 more
core
Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. [PDF]
BACKGROUND: Available literature concerning the epidemiologic or clinical features of vulvovaginal candidiasis commonly reports that: 75% of women will experience an episode of vulvovaginal candidiasis in their lifetimes, 50% of whom will experience at ...
Patricia A Buffler +3 more
core +2 more sources
The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis [PDF]
Host immunity against Candida albicans is crucial in controlling C. albicans infection. The innate immunity is believed to be the first line of host defense, such as the direct killing of yeasts through phagocytosis by neutrophils and macrophages.
Sh M Pogosyan +4 more
doaj
Introducción: la infección por Cándida es la segunda causa de consulta al ginecólogo después de la vulvovaginitis bacteriana. Las causas son multifactoriales.
Sacoto Ullauri, Gustavo Eugenio
core
Background and Aim: Vulvovaginal candidiasis (VVC) is a vaginal fungal infection that mainly caused by Candida albicans. Among various treatments and their controversial outcomes, oral fluconazole has been accepted as a common and efficient treatment for
Zahra Vahedpoor +4 more
doaj
The impact of oral contraception on vulvovaginal candidiasis
To evaluate risk factors related to sociodemographic and clinical variables, oral contraception and sexual behavior of women with recurrent vulvovaginal candidiasis, we conducted a case-control study comparing 153 patients with recurrent vulvovaginal ...
Ferrari A +5 more
core +1 more source
Preconception preparation of patients with reccurent vulvovaginal candidiasis with the use of immunomodulation therapy [PDF]
Preconception preparation of patients with reccurent vulvovaginal candidiasis with the use of immunomodulation therapy I.O. Borovikov, A.S. Avetisian Kuban state medical university, Krasnodar, Russian Federation The article considers ...
Borovikov I.O., A.S. Avetisian
doaj
This scoping review aims to compile and analyze epidemiological data from studies carried out on vulvovaginal candidiasis in the Northeast region of Brazil.
Raimundo euzebio da costa neto
core +1 more source
Treatment for recurrent vulvovaginal candidiasis (thrush) (Protocol)
This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective of this systematic review is to assess the relative efficacy of pharmacological and non-pharmacological treatments for recurrent vulvovaginal
Cathy Watson +9 more
core +1 more source
Predisposing factors of recurrent vulvovaginal candidiasis III.
1 ABSTRACT In this study we are dealing with problems of recurrent vulvovaginal candidiasis. Vulvovaginal candidiasis is one of the most frequent genital infections. It is hypothesized that 75% of woman experience during their reproductive age at least 1
Hájková, Lucie
core +1 more source

